Clinical trial NCT02869048 - References

Amyotrophic Lateral Sclerosis — Amyotrophic Lateral Sclerosis and the Innate Immune System

Citation(s)

•   Andersen PM, Al-Chalabi A
  Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011 Oct 11;7(11):603-15. doi: 10.1038/nrneurol.2011.150. Review.
•   Annunziata P, Volpi N
  High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients. Acta Neurol Scand. 1985 Jul;72(1):61-4.
•   Apostolski S, Nikolic J, Bugarski-Prokopljevic C, Miletic V, Pavlovic S, Filipovic S
  Serum and CSF immunological findings in ALS. Acta Neurol Scand. 1991 Feb;83(2):96-8.
•   Armitage P BG
  Statistical Methods for Medical Researchers. Blackwell1994.
•   Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases
  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9. Review.
•   Chiò A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA
  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118-30. doi: 10.1159/000351153. Epub 2013 Jul 11. Review.
•   Conradi S, Ronnevi LO
  Cytotoxic activity in the plasma of amyotrophic lateral sclerosis (ALS) patients against normal erythrocytes. Quantitative determinations. J Neurol Sci. 1985 May;68(2-3):135-45.
•   Conradi S, Ronnevi LO
  Immunoglobulin-mediated cytotoxic effect of ALS-plasma towards erythrocytes: reflexion of a pathogenetic mechanism? Adv Exp Med Biol. 1987;209:7-13.
•   Conradi, S
  Cytotoxic factor in plasma from ALS patients provokes haemolysis of normal erythrocytes. Acta Neurologica Scandinavica, 65: 246-247, 1982
•   Digby J, Harrison R, Jehanli A, Lunt GG, Clifford-Rose F
  Cultured rat spinal cord neurons: interaction with motor neuron disease immunoglobulins. Muscle Nerve. 1985 Sep;8(7):595-605.
•   Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD
  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004 Feb;185(2):232-40.
•   Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P
  Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci. 2000 Apr 1;20(7):2534-42.
•   Goldknopf IL, Sheta EA, Bryson J, Folsom B, Wilson C, Duty J, Yen AA, Appel SH
  Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Biochem Biophys Res Commun. 2006 Apr 21;342(4):1034-9. Epub 2006 Feb 20.
•   Grewal RP, Morgan TE, Finch CE
  C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis. Neurosci Lett. 1999 Aug 13;271(1):65-7.
•   Heurich B, El Idrissi NB, Donev RM, Petri S, Claus P, Neal J, Morgan BP, Ramaglia V
  Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis. J Neuroimmunol. 2011 Jun;235(1-2):104-9. doi: 10.1016/j.jneuroim.2011.03.011. Epub 2011 Apr 17.
•   Kawamata T, Akiyama H, Yamada T, McGeer PL
  Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol. 1992 Mar;140(3):691-707.
•   Kong J, Xu Z
  Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci. 1998 May 1;18(9):3241-50.
•   Lee JD, Kamaruzaman NA, Fung JN, Taylor SM, Turner BJ, Atkin JD, Woodruff TM, Noakes PG
  Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis. J Neuroinflammation. 2013 Sep 26;10:119. doi: 10.1186/1742-2094-10-119.
•   Liveson J, Frey H, Bornstein MB
  The effect of serum from ALS patients on organotypic nerve and muscle tissue cultures. Acta Neuropathol. 1975 Aug 11;32(2):127-31.
•   Lobsiger CS, Boillée S, Cleveland DW
  Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc Natl Acad Sci U S A. 2007 May 1;104(18):7319-26. Epub 2007 Apr 26.
•   Lobsiger CS, Boillée S, Pozniak C, Khan AM, McAlonis-Downes M, Lewcock JW, Cleveland DW
  C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice. Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):E4385-92. doi: 10.1073/pnas.1318309110. Epub 2013 Oct 29.
•   Miller RG, Mitchell JD, Moore DH
  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2012 Mar 14;(3):CD001447. doi: 10.1002/14651858.CD001447.pub3. Review.
•   Overgaard K, Werdelin L, Sørensen H, Mogensen P, Boysen G
  Cytotoxic activity in plasma from patients with amyotrophic lateral sclerosis. Neurology. 1991 Jun;41(6):925-7.
•   Phukan J, Pender NP, Hardiman O
  Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007 Nov;6(11):994-1003. Review.
•   Pinter MJ, Waldeck RF, Wallace N, Cork LC
  Motor unit behavior in canine motor neuron disease. J Neurosci. 1995 May;15(5 Pt 1):3447-57.
•   Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O'Toole O, Wingerchuk DM
  Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol. 2013 Jun;12(6):554-62. doi: 10.1016/S1474-4422(13)70076-0. Epub 2013 Apr 26.
•   Pun S, Santos AF, Saxena S, Xu L, Caroni P
  Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci. 2006 Mar;9(3):408-19. Epub 2006 Feb 12.
•   Roisen FJ, Bartfeld H, Donnenfeld H, Baxter J
  Neuron specific in vitro cytotoxicity of sera from patients with amyotrophic lateral sclerosis. Muscle Nerve. 1982 Jan;5(1):48-53.
•   Ronnevi LO, Conradi S, Karlsson E, Sindhupak R
  Nature and properties of cytotoxic plasma activity in amyotrophic lateral sclerosis. Muscle Nerve. 1987 Oct;10(8):734-43.
•   Ronnevi, LO
  , Conradi, S. and Karlsson, E. Cytotoxic effect of immunoglobulins in Amyotrophic Lateral Sclerosis (ALS). Acta Neurologica Scandinavica, 69: 182-183, 1984
•   Seals RM, Hansen J, Gredal O, Weisskopf MG
  Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009. Am J Epidemiol. 2013 Oct 15;178(8):1265-71. doi: 10.1093/aje/kwt116. Epub 2013 Sep 24.
•   Sta M, Sylva-Steenland RM, Casula M, de Jong JM, Troost D, Aronica E, Baas F
  Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation. Neurobiol Dis. 2011 Jun;42(3):211-20. doi: 10.1016/j.nbd.2011.01.002. Epub 2011 Jan 8.
•   Tsuboi Y, Yamada T
  Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1994 Jul;57(7):859-61.
•   Tümer Z, Bertelsen B, Gredal O, Magyari M, Nielsen KC, Lucamp, Grønskov K, Brøndum-Nielsen K
  Novel heterozygous nonsense mutation of the OPTN gene segregating in a Danish family with ALS. Neurobiol Aging. 2012 Jan;33(1):208.e1-5. doi: 10.1016/j.neurobiolaging.2011.07.001. Epub 2011 Aug 26.
•   Wolfgram F, Myers L
  Amyotrophic lateral sclerosis: effect of serum on anterior horn cells in tissue culture. Science. 1973 Feb 9;179(4073):579-80.
•   Woodruff TM, Costantini KJ, Crane JW, Atkin JD, Monk PN, Taylor SM, Noakes PG
  The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. J Immunol. 2008 Dec 15;181(12):8727-34.

Amyotrophic Lateral Sclerosis and the Innate Immune System

Details for clinical trial NCT02869048